NHNicole Hantakova

Nicole Hantakova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nicole Hantakova has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Alexandra Graf

    Medical University of Vienna

    2 shared publications
  • Barbara Kabon

    Center for Outcomes Research, UTHealth, Houston, Texas; Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Division of General Anaesthesia and Intensive Care Medicine, Medical University of Vienna, Vienna, Austria

    2 shared publications
  • Edith Fleischmann

    Center for Outcomes Research, UTHealth, Houston, Texas; Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Division of General Anaesthesia and Intensive Care Medicine, Medical University of Vienna, Vienna, Austria

    2 shared publications
  • Katharina Horvath

    Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Division of General Anaesthesia and Intensive Care Medicine, Medical University of Vienna, Vienna, Austria

    2 shared publications
  • Nikolas Adamowitsch

    Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Division of General Anaesthesia and Intensive Care Medicine, Medical University of Vienna, Vienna, Austria

    2 shared publications
  • Alexander Christian Reisinger

    Department of Internal Medicine, Intensive Care Unit, Medical University of Graz, Graz, Austria

    1 shared publication

Latest Publications

  • Open Access

    Effect of Preoperative Intravenous Crystalloid Bolus on Postinduction Blood Pressure: A Randomized Blinded Intervention Trial

    by Michael Eichinger, Christian Reiterer, Michael Eichlseder, Alexander Pichler, Alexander Taschner, Katharina Horvath, Hani Essber, Daniel Freidorfer, Nikolas Adamowitsch, Nicole Hantakova, et al.

    Background: Postinduction hypotension in major noncardiac surgery is common and a modifiable risk factor for adverse outcomes. There is an ongoing debate whether preoperative crystalloid fluid administration can reduce the incidence or severity of postinduction hypotension. This study aims to assess whether a preoperative intravenous crystalloid bolus reduces postinduction hypotension in high-risk patients during general anesthesia. Methods: This was a prospective, randomized, single-blind clinical trial conducted at two centers in Austria (Medical University of Graz, Medical University of Vienna). Adult patients 45 yr and older with cardiovascular risk factors undergoing major surgery were enrolled and randomly assigned to receive a preoperative crystalloid bolus within 60 ± 15 min before anesthetic induction, or to receive standard care. The primary outcome was the time-weighted average mean arterial pressure of less than 65 mmHg within the first 20 min after induction or until surgical incision. Results: Of the 504 patients analyzed (247 in the intervention group and 257 in the control group), no statistically significant difference in median time-weighted average of the mean arterial pressure less than 65 mmHg was observed (intervention group, 0.0 mmHg; interquartile range, 0.0 to 0.56; standard of care group, 0.0 mmHg; interquartile range, 0.0 to 0.84; P = 0.368). Conclusions: In this blinded randomized clinical trial, administering a crystalloid fluid bolus within 60 min before surgery did not significantly reduce the time-weighted average of a mean arterial pressure less than 65 mmHg compared to standard care in patients with cardiovascular risk factors undergoing major noncardiac surgery. This study suggests that administering crystalloids before surgery does not prevent postinduction hypotension.


  • Open Access

    Levosimendan and Postoperative Renal Function in Patients with Cardiovascular Risk Factors Undergoing Major Noncardiac Surgery – Secondary Analysis of a Double-Blinded Randomized-Controlled Trial

    by Nicole Hantakova, Christian Reiterer, Barbara Kabon, Alexander Taschner, Nikolas Adamowitsch, Katharina Horvath, Zotti Olliver, Melanie Fraunschiel, Theresa Clement, Edith Fleischmann, et al.

    Background: Acute kidney injury (AKI) is a common and serious complication after noncardiac surgery. While levosimendan has shown renal protective effects in cardiac surgery patients, its impact in non-cardiac surgery – especially among patients with cardiovascular risk factors – remains unknown. Therefore, in this secondary analysis, we evaluated the effect of perioperative levosimendan administration on the incidence of postoperative AKI. We further assessed its impact on perioperative maximum creatinine concentration, estimated glomerular filtration rate (eGFR), and perioperative body composition parameters.Methods: We included all 228 patients from the main trial. Among these, 115 patients were assigned to receive a single dose of levosimendan, while113 patients were allocated to the placebo group. Blood samples and body composition parameters were assessed preoperatively, within one hour after surgery, and on the first, second, third and fifth postoperative day.Results: The incidence of postoperative AKI (p=0.485) did not differ significantly; also, the logistic regression model showed no significant treatment effect between the groups (OR 1.348, 95% CI 0.466 to 4.086; p=0.584). Maximum creatinine concentrations (effect estimate: 0.04 mg.dL-1, 95% CI -0.07 to 0.15; p=0.481), eGFR (effect estimate -1.01mL.min-1.BSA, 95% CI -6.98 to 4.97; p=0.743), and postoperative overhydration were also similar between the groups.Conclusion: Unlike findings in cardiac surgery patients, perioperative levosimendan administration did not provide renal protection in high-risk cardiovascular patients undergoing major noncardiac surgery.